Lending Our Support
Medpace is an active member of the Alliance
for Regenerative Medicine, a Washington, DC-based non-profit organization
whose mission is to educate key policy makers about the potential of
regenerative medicine and to advocate for favorable public policies—funding,
regulatory, reimbursement and others—to facilitate advances in the field.
Downloads and Links
Aging global populations are a factor demanding that drug therapies for neurologic diseases are needed now more than
ever. At Medpace, our goal as a full-service CRO is to understand the need for speed and combine that with well-integrated,
therapeutically focused medical teams to help you bring your drug to market in the most efficient way possible.
Medpace, a global full-service CRO, is a best-in-class strategic partner for sponsors in neuroscience drug development.
Key industry leaders, who have a deep knowledge of Neuroscience development best practices, knowledge of core imaging project
management, regulatory issues, and noted relationships with key investigative sites, assure your projects are completed on time and on budget.
Integrated Project Teams
Over the past 13 years, Medpace has been involved in trials focused in neurology and psychiatry. This experience is a direct result of well-established Sponsor relationships, exceptional clinical operations, and committed study teams. Medpace has built a team that includes a Neurologist, a Psychiatrist, a Clinical Trial Manager with a PhD in Neuroscience, and several Clinical Trial Managers who have been involved with the management and execution of CNS trials from the Sponsor/CRO project management role and the site study coordination/patient care perspective. All team members are involved from project initiation to completion, producing truly seamless drug development.
Sites are located in US, Canada, Eastern and Western Europe, and Central and Latin America.
Core Imaging Expertise for Neurologic Trials
Medpace Core Imaging Lab provides an end-to-end suite of imaging services to enhance and expedite biopharmaceutical and imaging contrast agent development, including consultation on imaging biomarker strategies, image acquisition protocols, image collection/archiving services, and image analysis across imaging modalities and therapeutic areas. Led by a medical team with extensive clinical trial experience in neurosciences including Alzheimer's Disease and stroke, Imagepace provides centralized lab capabilities for managing standard, as well as innovative, imaging modality including magnetic resonance imaging (MRI), computed tomography (CT), and bone densitometry or dual-energy x-ray absorptiometry (DXA).
- Neuropathic pain
- Alzheimer's Disease
- Diabetic Neuropathy
- Parkinson's Disease
- Multiple Sclerosis
- Sleep-Wake disorder
- Psychiatry disorders
>> Click here to learn more about Medpace's capabilities and therapeutic focus on Neuroscience.